Result Summary for LAMPOL4002
| Protocol ID: | LAMPOL4002 |
| Clinical Study ID: | LAMPOL4002 |
| Official Title: | A multicentre, open study to estimate the effect of Lamivudine on liver histology and HBV DNA clearance in patients with chronic hepatitis B |
| Phase: | Phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | lamivudine |
| Trade/Product Name: | epivir;epivir |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
